Tagged Articles

brain tumors 2 articles

Bristol-Myers Squibb recalls chemotherapy drug

More than 31,000 units of a chemotherapy drug are being recalled by manufacturer Bristol-Myers Squibb Co., because one vial was found to be overfilled, which puts patients at risk for overdose. The recall affects 10 lots of BiCNU, an injection of the drug carmustine, which is used to treat brain tumors, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s lymphoma. An overdose of BiCNU could result in lung or kidney toxicity. No adverse events have yet been reported. BiCNU was manufactured by Ben Venue Laboratories, a manufacturing contractor that Bristol-Myers Squibb no longer uses. The recall affects products sold in the United ... Read More

FDA warns surgeons about malfunctioning brain mapping device

A machine used by physicians to conduct brain mapping procedures for patients with brain tumors and seizure disorders – including those caused by Traumatic Brain Injuries (TBI) – is being recalled because of a malfunction and short circuiting issue that can result in the surgeon resecting the wrong brain tissue. This recall is classified as a Class 1, which is the most serious type of recall, involving situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death. The recall involves the CareFusion is recalling Nicolet Cortical Stimulator Control Unit, ... Read More